Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Treatment significantly increased serum testosterone and nitric oxide (NO) levels and improved sexual organs weights and behaviors in male mice compared to other medicinal materials [PMID:29987881]. It also elicited a significant increase in penile intracavernous pressure (ICP) in rats [PMID:16527595].
Extracts and polysaccharides from E. brevicornum prevent estrogen-deficiency-induced and glucocorticoid-induced osteoporosis in rats and in vitro by promoting osteoblast proliferation and differentiation [PMID:16413840, 31751710]. It also alleviates diabetes-induced osteoporosis by regulating the AGE-RAGE pathway [PMID:40089686].
Icariin attenuated learning and memory deficits induced by d-galactose in rats by elevating mRNA and protein expressions of BDNF and TrkB in the hippocampus [PMID:20566405].
Epimedokoreanin B inhibited tumor progression in mouse models by targeting the MCOLN1/TRPML1 channel, blocking autophagic flux and triggering apoptosis [PMID:40846097].
Icariin reduced endothelial atherosclerotic plaque area and collagen fibers in aortic sinus tissue of atherosclerotic mice by promoting autophagy [PMID:37344941].
Synthèse des preuves
Sources PubMed
- 1.PMID: 37331450 (2023) — Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization. · Journal of ethnopharmacology
- 2.PMID: 37344941 (2023) — Icariin alleviates ferroptosis-related atherosclerosis by promoting autophagy in xo-LDL-induced vascular endothelial cell injury and atherosclerotic mice. · Phytotherapy research : PTR
- 3.PMID: 40089686 (2025) — Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway. · Molecular medicine (Cambridge, Mass.)
- 4.PMID: 36249817 (2022) — Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer. · Frontiers in pharmacology
- 5.PMID: 40846097